Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 10, 2006. The document serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding their interests in the company's Ordinary Shares.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is strictly a regulatory disclosure of share transactions and does not contain financial performance data.
Material Changes
The filing details the acquisition of Ordinary Shares by four individuals (Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty) on November 9, 2006. Each individual acquired 9 shares through the personal contribution element and 9 shares through the matching element of the Company's ShareReward Plan. The transaction price was GBP 13.82 per Ordinary Share.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to the notification of the specific share transactions described above.
Key Facts for Investor Verification
- Transaction Date: November 9, 2006.
- Share Price: GBP 13.82 per Ordinary Share.
- Participants: Mr. J S Heslop, Mr. R Bondy, Mr. D Learmouth, and Mr. A P Witty.
- Volume: Each participant acquired a total of 18 shares (9 personal, 9 company match).
- Plan Details: Transactions occurred under the ShareReward Plan entered into on October 5, 2001.